NEEMA Published Papers – Tuberculosis
Raz KM, Talarico S, Althomsons SP, Kammerer JS, Cowan LS, Haddad MB, McDaniel CJ, Wortham JM, France AM, Powell KM, Posey JE, Silk BJ. Molecular surveillance for large outbreaks of tuberculosis in the United States, 2014-2018. Tuberculosis (Edinb). 2022 Aug 9;136:102232.
Shrestha, S., Winglee, K., Hill, A., Shaw, T., Smith, J., Kammerer, J. S., Silk, B. J., Marks, S., & Dowdy, D. (2022). Model-based analysis of tuberculosis genotype clusters in the United States reveals high degree of heterogeneity in transmission, and state-level differences across California, Florida, New York, and Texas. Clinical Infectious Diseases.
Kim S, Cohen T, Horsburgh CR, Miller JW, Hill AN, Marks SM, Li R, Kammerer JS, Salomon JA, Menzies NA. Trends, Mechanisms, and Racial/Ethnic Differences of Tuberculosis Incidence in the US-Born Population Aged 50 Years or Older in the United States. Clin Infect Dis. 2022 May 3;74(9):1594-1603.
Smith JP, Gandhi NR, Silk BJ, Cohen T, Lopman B, Raz K, Winglee K, Kammerer S, Benkeser D, Kramer MR, Hill AN. A Cluster-based Method to Quantify Individual Heterogeneity in Tuberculosis Transmission. Epidemiology. 2022 Mar 1;33(2):217-227.
Menzies, Nicolas A.a; Shrestha, Souryab; Parriott, Andreac; Marks, Suzanne M.d; Hill, Andrew N.d; Dowdy, David W.b; Shete, Priya B.e; Cohen, Tedf; Salomon, Joshua A.g. The Health and Economic Benefits of Tests That Predict Future Progression to Tuberculosis Disease. Epidemiology : January 2022 – Volume 33 – Issue 1 – p 75-83.
Hill AN, Cohen T, Salomon JA, Menzies NA. High-resolution estimates of tuberculosis incidence among non-U.S.-born persons residing in the United States, 2000-2016. Epidemics. 2020 Dec;33:100419. Menzies NA, Shrestha S, Parriott A, Marks SM, Hill AN, Dowdy DW, Shete PB, Cohen T, Salomon JA. The health and economic benefits of tests that predict future progression to TB disease. Epidemiology. In press 2021.
Mirzazadeh A, Fellow IE, Ashki H, Parriott A, Readhead A, Barry P, Flood J, Navin TR, Hill AN, Reynolds S, Marks S, McCabe D, Mermin J, Kahn JG, Shete PB. Estimating Latent Tuberculosis Infection Prevalence in the United States: Back-Calculation from Active TB Cases. PLOS ONE. In press 2021.
Menzies NA, Swartwood N, Testa C, Malyuta Y, Hill AN, Marks SM, Cohen T, Salomon JA. Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States. Epidemiology. 2021 Jan;32(1):70-78.
Hill AN, Cohen T, Salomon JA, Menzies NA. High-resolution estimates of tuberculosis incidence among non-U.S.-born persons residing in the United States, 2000-2016. Epidemics. 2020 Dec;33:100419.
Shrestha S, Parriott A, Menzies NA, Shete PB, Hill AN, Marks SM, Dowdy DW. Estimated Population-Level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States. Annals of the American Thoracic Society. 2020 Dec;17(12):1639-1642.
Menzies NA, Bellerose M, Testa C, Swartwood N, Malyuta Y, Cohen T, Marks SM, Hill AN, Date A, Maloney SA, Bowden S, Grills A, Salomon JA. Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States. American Journal of Respiratory and Critical Care Medicine. 2020 Dec 1;202(11):1567-1575.
Marks SM, Dowdy DW, Menzies NA, Shete PB, Salomon JA, Parriott A, Shete PB, Shrestha S, Dowdy DW, Flood J, Hill AN. Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate TB Elimination. Public Health Reports. 2020;135(1:supplement).
Parriott A, Shete PB, Readhead A, Barry PM, Flood J, Kahn JG. Modelling the Impact of Recommendations for Primary Care-Based Screening for Latent Tuberculosis Infection in California. Public Health Reports. 2020;135(1:supplement).
Jo Y, Shrestha S, Gomes I, Marks S, Hill A, Asay G, and Dowdy D. Model-Based Cost-Effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York and Texas. Clin Infect Dis. doi:10.1093/cid/ciaa857 June 2020. PMCID: PMC807772
Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay G, Barry P. Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California. American Journal of Respiratory and Critical Care Medicine. 2019 Oct 18(ja).
Miller AP, Malekinejad M, Horváth H, Blodgett JC, Kahn JG, Marks SM. Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-US-born population in the United States: A systematic review. PloS One. 2019;14(9).
Shrestha S, Cherng S, Hill AN, Reynolds S, Flood J, Barry PM, Readhead A, Oxtoby M, Lauzardo M, Privett T, Marks SM. Impact and Effectiveness of State-level Tuberculosis Interventions in California, Florida, New York and Texas: A Model-based Analysis. American journal of epidemiology. 2019 Jun 28.
Goodell AJ, Shete PB, Vreman R, McCabe D, Porco TC, Barry PM, Flood J, Marks SM, Hill A, Cattamanchi A, Kahn JG. Outlook for Tuberculosis Elimination in California: An Individual-based Stochastic Model. PloS one. 2019 Apr 9;14(4):e0214532.
Menzies NA, Hill AN, Cohen T, Salomon JA. The impact of migration on tuberculosis in the United States. The International Journal of Tuberculosis and Lung Disease. 2018 Dec 1;22(12):1392-403.
Cherng, S. T., Shrestha, S., Reynolds, S., Hill, A. N., Marks, S. M., Kelly, J., Dowdy, D. W. Tuberculosis Incidence Among Populations at High Risk in California, Florida, New York, and Texas, 2011–2015, American Journal of Public Health 2018 Nov;108(S4):S311-4. Accessed 11/7/2018.
Parriott A, Malekinejad M, Miller AP, Horvath H, Marks SM, Kahn JG. Yield of Testing and Treatment for Tuberculosis Among Foreign-Born Persons During Contact Investigations in the United States: A Semi-Systematic Review. PLoS ONE. 2018 Jul 19;13(7):e0200485.
Menzies NA, Cohen T, Hill AN, Yaesoubi R, Galer K, Wolf E, Marks SM, Salomon JA. Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model. American Journal of Epidemiology. 2018 May 14;187(9):2011-20.
Parriott A, Malekinejad M, Miller AP, Marks SM, Horvath H, Kahn JG. Care Cascade for Targeted Tuberculosis Testing and Linkage to Care in Homeless Populations in the United States: a Meta-Analysis. BMC Public Health. 2018 Apr 12;18(1):485. Accessed 5/18/2018.
Menzies NA, Wolf E, Connors D, Bellerose M, Sbarra AN, Cohen T, Hill AN, Yaesoubi R, Galer K, White PJ, Abubakar I, Salomon JA. Progression from Latent Infection to Active Disease in Dynamic Tuberculosis Transmission Models: a Systematic Review of the Validity of Modelling Assumptions. The Lancet Infectious Diseases. 2018 Apr 10. Accessed 5/18/2018.
Tasillo A, Salomon JA, Trikalinos TA, Horsburgh CR, Marks SM, Linas BP. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model. JAMA Internal Medicine. 2017 Dec 1;177(12):1755-1764. Accessed 2/9/2018.
Malekinejad M, Parriott A, Viitanen AP, Horvath H, Marks SM, Kahn JG. Yield of Community-Based Tuberculosis Targeted Testing and Treatment in Foreign-Born Populations in the United States: A Systematic Review. PloS one. 2017 Aug 7;12(8):e0180707.
Shrestha S, Hill AN, Marks SM, Dowdy DW. Comparing Drivers and Dynamics of Tuberculosis (TB) in California, Florida, New York and Texas. American Journal of Respiratory And Critical Care Medicine. 2017 May 5(ja). Accessed 6/9/2017.